Biocon starts campaign to treat diabetic children, train healthcare workers

India has one of the largest populations of children and adolescents living with Type 1 diabetes in the world with an estimated 1 million patients in this age group

Biocon Biologics will enable free supply of insulin to 1,000 children from marginalised communities suffering from Type 1 diabetes, the company said on Monday.

The pharma major has tied up with the Research Society for the Study of Diabetes in India (RSSDI), an organisation of researchers and healthcare professionals for diabetes, to launch a campaign for diabetes knowledge in Type 1 patients.

To address the issue of Type 1 diabetes in children, Biocon Biologics will work together with RSSDI to identify and train around 400 physicians in different districts across the country.

India has one of the largest populations of